As a regulatory professional, confidence comes from having the answers you need. But what do you do when the answers just aren't there? 2014 RAPS will give you the know-how to tackle your toughest issues.
10/1/2014 - 11/30/2014
Improve how effectively you network and advocate for yourself with ideas and techniques from this on-demand webcast.
Local or global—RAPS has you covered with offices in Washington, DC, Shanghai and Singapore. There are RAPS chapters in Canada, Israel, Switzerland, Taiwan and throughout the United States, and local networks in Australia, Belgium, Brazil, Germany, India, Mexico, The Netherlands, Poland and Singapore.
Placeholder for Higher Logic Forum Discussions - DO NOT DELETE
Among the sessions at 2014 RAPS: The Regulatory Convergence are some that stand out to me, your Regulatory Focus editor, as particularly exciting—sessions that cover important topics, emerging trends, new developments and the critical aspects of actually being a regulatory professional.
The US Food and Drug Administration (FDA) has sent a warning to Cipher Pharmaceuticals over an email marketing piece sent by the company to promote its cholesterol drug Lipofen, saying the piece over-stated the drug's effectiveness.
A new government project is calling for help from the pharmaceutical industry to make what will be, in effect, a Facebook for drugs.
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.